Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Intel Strategy for Achieving Wealth and Off Topic -- Ignore unavailable to you. Want to Upgrade?

To: Sonki who wrote (17244)	2/7/1998 6:34:00 PM
From: Scooter	Respond to of 27012

Sonki--I believe my favorite analyst L Painter moved her target to $90 on CPQ, or $45 now. I think the DEC merger is going to be huge for CPQ. DEC has a great service division and $1.3 billion in cash. The cultures won't mesh overnight obviously, but I'm confident. Regards, Scooter

To: Sonki who wrote (17244)	2/7/1998 7:22:00 PM
From: Sonny McWilliams	Respond to of 27012

Sonki, and all CPQ and Dell holders. I see you came out of the rain to visit us? CPQ. I am not quite sure if I understood you correctly. Did you say ML moved target to 125 on CPQ or was that just your musings? Yes, ML had CPQ at a target of 100 before the deal with Dec, but then reduced it to 90, also before the split. Yes, CPQ will have their work cut out on that merger but I think CPQ's CEO E. Pfeiffer will handle it, hopefully. In the meantime I will get more CPQ. zdnet.com If you read this article make sure you also read the other write-ups on that site about CPQ/Dec. Glad to hear Dell is still going to 125 considering it's already at 190. gg. How are you and your house holding out in this weather. I see that y'all getting more rain. Sonny

To: Sonki who wrote (17244)	2/8/1998 1:44:00 PM
From: Brian Malloy	Read Replies (2) \| Respond to of 27012

Sonki, Sonny and other MRK holders on the thread. More Good news on the MERCK pipeline. It looks like we may get a COX2 class drug in early 99. Seale and MRK appear to be in the lead on this. Very high potential, looking at a 5 Billion+ market in early\mid next decade. A REVOLUTION IN PAIN RELIEF? A new class of breakthrough drugs is on the way businessweek.com Here Come the New Painkillers Some big drug companies are pushing a new class of painkillers called COX-2 inhibitors businessweek.com